Skip to menu Skip to content Skip to footer

2002

Conference Publication

Insulin-like growth factor (IGF)-I stimulates in vitro human renal cell carcinoma (RCC) growth

Cheung, C., Vesey, D. A., Gobe, G., Nicol, D. L. and Johnson, D. W. (2002). Insulin-like growth factor (IGF)-I stimulates in vitro human renal cell carcinoma (RCC) growth. Australian and New Zealand Society of Nephrology 37th Annual Scientific Meeting, Darwin, Australia, 5-7 September, 2001. Carlton, Vic.: Blackwell Science. doi: 10.1046/j.1440-1797.2002.00007-1-15.x

Insulin-like growth factor (IGF)-I stimulates in vitro human renal cell carcinoma (RCC) growth

2002

Conference Publication

Is mycophenolate mofetil (MMF) less safe than azathioprine in older renal transplant patients?

Johnson, D. W., Nicol, D., Campbell, S. B., Petrie, J., Hawley, C. M. and Isbel, N. M. (2002). Is mycophenolate mofetil (MMF) less safe than azathioprine in older renal transplant patients?. Australian and New Zealand Society of Nephrology 37th Annual Scientific Meeting, Darwin, N. T., 5th - 7th September, 2001. Carlton, Victoria: Blackwell Science. doi: 10.1046/j.1440-1797.2002.00007-1-89.x

Is mycophenolate mofetil (MMF) less safe than azathioprine in older renal transplant patients?

2002

Conference Publication

A randomised controlled trial of topical exit site mupirocin application in patients with cuffed haemodialysis catheters

Johnson, D. W., Kay, T. D., MacGinley, R. and Hollett, P. (2002). A randomised controlled trial of topical exit site mupirocin application in patients with cuffed haemodialysis catheters. 37th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Darwin, NT, 5th - 7th September, 2001. Carlton, VIC: Blackwell Science. doi: 10.1046/j.1440-1797.2002.00007-1-140.x

A randomised controlled trial of topical exit site mupirocin application in patients with cuffed haemodialysis catheters

2002

Conference Publication

Neutrophil Dysplasia Characterized by the Acquired Pelger-Huet Anomaly occurring with the Combination of Mycophenolate Mofetil and Ganciclovir Post Renal Transplantation: A Report of 5 Cases

Kay, T. D., Kennedy, G. A., Hawley, C. M., Campbell, S. B., Isbel, N. M., Marlton, P., Cobcroft, R., Gill, D., Cull, G. and Johnson, D. W. (2002). Neutrophil Dysplasia Characterized by the Acquired Pelger-Huet Anomaly occurring with the Combination of Mycophenolate Mofetil and Ganciclovir Post Renal Transplantation: A Report of 5 Cases. Australian and New Zealand Society of Nephrology 37th Annual Scientific Meeting, Darwin, NT Australia, 5 - 7 September 2001. Richmond, VIC Australia: Wiley-Blackwell. doi: 10.1046/j.1440-1797.2002.00007-1-83.x

Neutrophil Dysplasia Characterized by the Acquired Pelger-Huet Anomaly occurring with the Combination of Mycophenolate Mofetil and Ganciclovir Post Renal Transplantation: A Report of 5 Cases

2002

Conference Publication

Acute rejection is more common and severe in live donor than cadeveric donor kidney transplants

Johnson, D. W., Isbel, N. M., Hawley, C. M., Nicol, D. L. and Campbell, S. B. (2002). Acute rejection is more common and severe in live donor than cadeveric donor kidney transplants. Australian and New Zealand Society of Nephrology 37th Annual Scientific Meeting, Darwin, N.T., 5-7 September 2001. Carlton, Vic.: Blackwell Science. doi: 10.1046/j.1440-1797.2002.00007-1-110.x

Acute rejection is more common and severe in live donor than cadeveric donor kidney transplants

2002

Conference Publication

Icodextrin as salvage therapy in peritoneal dialysis patients with refractory fluid overload

Johnson, David W., Arndt, Mary, O'Shea, Amanda, Watt, Rhonda, Hamilton, Jan and Vincent, Kaia (2002). Icodextrin as salvage therapy in peritoneal dialysis patients with refractory fluid overload. Australian and New Zealand Society of Nephrology 37th Annual Scientific Meeting, Darwin, N.T., 5th - 7th September, 2001. Carlton, Victoria: Blackwell Science.

Icodextrin as salvage therapy in peritoneal dialysis patients with refractory fluid overload

2002

Conference Publication

The effect of obesity on renal transplant outcomes

Johnson, D. W., Isbel, N., Kay, T. D., Hawley, C., Campbell, S. B. and Nicol, D. L. (2002). The effect of obesity on renal transplant outcomes. Australian and New Zealand Society of Nephrology 37th Annual Scientific Meeting, Darwin, N. T., 5th - 7th September, 2001. Carlton, Victoria: Blackwell Science. doi: 10.1046/j.1440-1797.2002.00007-1-39.x

The effect of obesity on renal transplant outcomes

2002

Journal Article

Angiotensin converting enzyme inhibitors protect against renal injury via direct effects on the tubulointerstitium: evidence from cell cultures

Johnson, D. W. and Vesey, D. A. (2002). Angiotensin converting enzyme inhibitors protect against renal injury via direct effects on the tubulointerstitium: evidence from cell cultures. Health Science, 11 (3), 14-15.

Angiotensin converting enzyme inhibitors protect against renal injury via direct effects on the tubulointerstitium: evidence from cell cultures

2002

Journal Article

Interacting roles of myofibroblasts, apoptosis and fibrogenic growth factors in the pathogenesis of renal tubulo-interstitial fibrosis

Lane, Annette, Johnson, David W., Pat, Betty, Winterford, Clay, Endre, Zoltan, Wei, Ming and Gobe, Glenda C. (2002). Interacting roles of myofibroblasts, apoptosis and fibrogenic growth factors in the pathogenesis of renal tubulo-interstitial fibrosis. Growth Factors, 20 (3), 109-119. doi: 10.1080/0897719021000006181

Interacting roles of myofibroblasts, apoptosis and fibrogenic growth factors in the pathogenesis of renal tubulo-interstitial fibrosis

2002

Conference Publication

A cross-over trial comparing intravenous (IV) and oral iron supplementation in erythropoietin (EPO) - treated peritoneal dialysis (PD) patients

Johnson, David W., Herzig, Karen A., Campbell, Scott Bryan, Hawley, Carmel M. and Isbel, Nicole M. (2002). A cross-over trial comparing intravenous (IV) and oral iron supplementation in erythropoietin (EPO) - treated peritoneal dialysis (PD) patients. 37th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Darwin, 5th - 7th September, 2001. Carlton, Victoria: Blackwell Science. doi: 10.1046/j.1440-1797.2002.00007-1-63.x

A cross-over trial comparing intravenous (IV) and oral iron supplementation in erythropoietin (EPO) - treated peritoneal dialysis (PD) patients

2002

Book Chapter

The Effect of Body Mass Index on Peritoneal Dialysis Outcome

McDonald, Stephen, Johnson, David and Collins, John (2002). The Effect of Body Mass Index on Peritoneal Dialysis Outcome. Australia and New Zealand Dialysis and Transplant Registry: The 25th Report 2002. (pp. 114-117) edited by Stephen P. McDonald and Graeme R. Russ. Adelaide, South Australia.: ANZDATA Registry.

The Effect of Body Mass Index on Peritoneal Dialysis Outcome

2002

Conference Publication

Novel erythropoiesis stimulating protein (Darbepoietin Alpha) corrects anaemia of early chronic kidney disease recombinant human erythropoietin (rHuEPO)

Johnson, D. W. (2002). Novel erythropoiesis stimulating protein (Darbepoietin Alpha) corrects anaemia of early chronic kidney disease recombinant human erythropoietin (rHuEPO). Australian and New Zealand Society of Nephrology 37th Annual Scientific Meeting, Darwin, N. T., 5th - 7th September, 2001. Carlton, Victoria: Blackwell Science. doi: 10.1046/j.1440-1797.2002.00007-1-156.x

Novel erythropoiesis stimulating protein (Darbepoietin Alpha) corrects anaemia of early chronic kidney disease recombinant human erythropoietin (rHuEPO)

2002

Conference Publication

Translocation of Caveolin-1 in Renal Ischaemia-Reperfusion Injury

Mahmoudi, M., Willgoss, D., Cuttle, L., Endre, Z., Johnson, D. W. and Gobe, G. (2002). Translocation of Caveolin-1 in Renal Ischaemia-Reperfusion Injury. Australian and New Zealand Society of Nephrology 37th Annual Scientific Meeting, Darwin, N. T., 5th - 7th September, 2001. Carlton, Victoria: Blackwell Science.

Translocation of Caveolin-1 in Renal Ischaemia-Reperfusion Injury

2002

Conference Publication

Macrophage-colony stimulating factor (M-CSF): A risk factor for atherosclerosis in uraemia?

Isbel, N. M., Fathi, R., Kennedy, R., Haluska, B., Short, L., Hawley, C. M., Campbell, S. B., Marwick, T. and Johnson, D. W. (2002). Macrophage-colony stimulating factor (M-CSF): A risk factor for atherosclerosis in uraemia?. 37th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Darwin, N.T., 5th - 7th September, 2001. Carlton, Victoria: Blackwell Science. doi: 10.1046/j.1440-1797.2002.00007-1-140.x

Macrophage-colony stimulating factor (M-CSF): A risk factor for atherosclerosis in uraemia?

2001

Journal Article

Maintaining clearance in peritoneal dialysis

Johnson, David W. (2001). Maintaining clearance in peritoneal dialysis. Nephrology, 6 (6), 243-249. doi: 10.1046/j.1440-1797.2001.00042.x

Maintaining clearance in peritoneal dialysis

2001

Journal Article

A prospective crossover trial comparing intermittent intravenous and continuous oral iron supplements in peritoneal dialysis patients

Johnson, David W., Herzig, Karen A., Gissane, Ruth, Campbell, Scott B., Hawley, Carmel M. and Isbel, Nicole M. (2001). A prospective crossover trial comparing intermittent intravenous and continuous oral iron supplements in peritoneal dialysis patients. Nephrology Dialysis Transplantation, 16 (9), 1879-1884. doi: 10.1093/ndt/16.9.1879

A prospective crossover trial comparing intermittent intravenous and continuous oral iron supplements in peritoneal dialysis patients

2001

Journal Article

Mycophenolate mofetil for treatment of refractory lupus nephritis (Letter to the Editor)

Johnson, D. W. (2001). Mycophenolate mofetil for treatment of refractory lupus nephritis (Letter to the Editor). Internal Medicine Journal, 31 (5), 312-312. doi: 10.1046/j.1445-5994.2001.00059.x

Mycophenolate mofetil for treatment of refractory lupus nephritis (Letter to the Editor)

2001

Journal Article

The relationship of a clonal outbreak of Enterococcus faecium vanA to methicillin-resistant Staphylococcus aureus incidence in an Australian hospital

Bartley, P. B., Schooneveldt, J. M., Looke, D. F. M., Morton, A., Johnson, D. W. and Nimmo, G. R. (2001). The relationship of a clonal outbreak of Enterococcus faecium vanA to methicillin-resistant Staphylococcus aureus incidence in an Australian hospital. Journal of Hospital Infection, 48 (1), 43-54. doi: 10.1053/jhin.2000.0915

The relationship of a clonal outbreak of Enterococcus faecium vanA to methicillin-resistant Staphylococcus aureus incidence in an Australian hospital

2001

Journal Article

Is C-reactive protein a useful predictor of outcome in peritoneal dialysis patients?

Herzig, K. A., Purdie, D. M., Chang, W., Brown, A. M., Hawley, C. M., Campbell, S. B., Sturtevant, J. M., Isbel, N. M., Nicol, D. L. and Johnson, D. W. (2001). Is C-reactive protein a useful predictor of outcome in peritoneal dialysis patients?. Journal of the American Society of Nephrology, 12 (4), 814-821.

Is C-reactive protein a useful predictor of outcome in peritoneal dialysis patients?

2001

Journal Article

Does renal failure cause an atherosclerotic milieu in patients with end-stage renal disease?

Kennedy, Robert, Case, Colin, Fathi, Robert, Johnson, David, Isbel, Nicole and Marwick, Thomas H. (2001). Does renal failure cause an atherosclerotic milieu in patients with end-stage renal disease?. American Journal of Medicine, 110 (3), 198-204. doi: 10.1016/S0002-9343(00)00695-1

Does renal failure cause an atherosclerotic milieu in patients with end-stage renal disease?